Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity

Clinical and animal studies have demonstrated that chemotherapeutic doxorubicin (DOX) increases arterial stiffness, a predictor of cardiovascular risk. Despite consensus about DOX-impaired endothelium-dependent vasodilation as a contributing mechanism, some studies have reported conflicting results...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosman, Matthias, Krüger, Dustin N., Favere, Kasper, Wesley, Callan D., Neutel, Cédric H. G., Van Asbroeck, Birgit, Diebels, Owen R., Faes, Bart, Schenk, Timen J., Martinet, Wim, De Meyer, Guido R. Y., Van Craenenbroeck, Emeline M., Guns, Pieter-Jan D. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657832/
https://www.ncbi.nlm.nih.gov/pubmed/34884612
http://dx.doi.org/10.3390/ijms222312812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657832/
https://www.ncbi.nlm.nih.gov/pubmed/34884612
http://dx.doi.org/10.3390/ijms222312812

Ejemplares similares